Cambio de natalizumab a fingolimod: ¿reducción del período de lavado? / Switching therapy from natalizumab to fingolimod: reduction of the washout time?
Farm. hosp
; 39(5): 314-315, sept.-oct. 2015.
Article
in Spanish
| IBECS
| ID: ibc-143214
Responsible library:
ES1.1
Localization: BNCS
RESUMEN
No disponible
Full text:
Available
Collection:
National databases
/
Spain
Health context:
Sustainable Health Agenda for the Americas
Health problem:
Goal 9: Noncommunicable diseases and mental health
Database:
IBECS
Main subject:
Integrin alpha Chains
/
Antibodies, Monoclonal
/
Multiple Sclerosis
Limits:
Adult
/
Female
/
Humans
/
Male
Language:
Spanish
Journal:
Farm. hosp
Year:
2015
Document type:
Article
Institution/Affiliation country:
Gerencia Atención Integrada de Cuenca/España